Sars-Cov-2 B.1.1.529 (Omicron) variant outbreak: case series presentations and response to treatment at the Islamic University in Uganda health facility

N. Rashid
{"title":"Sars-Cov-2 B.1.1.529 (Omicron) variant outbreak: case series presentations and response to treatment at the Islamic University in Uganda health facility","authors":"N. Rashid","doi":"10.21303/2313-8416.2022.002369","DOIUrl":null,"url":null,"abstract":"The object of research: The study, investigated the clinical presentations of patients who tested Positive for Covid-19 (Omicron Variant), their response to treatment, and the levels of transmissibility of the infection. \nInvestigated problem: As the globe, continent, and nation are struggling with the emergency of the new COVID-19 omicron Virant outbreak there’s not much information known about the behavior of this new threat to enable clinicians, and public health specialists, and policymakers to curb the problem. \nThe main scientific results: The study found that headache, cough, fevers and, general body weakness was the commonest presenting complaints, 3 of the cases reported difficulties in breathing. None of the cases required admission. There was no difference in the severity of the illness and the response to treatment between the vaccinated and the non-vaccinated cases. Cases that did steaming as an adjuvant/supplementary treatment reported a shorter duration of symptomatic relief than those that did not. \nThe area of practical use of the research results: The findings will act as a practical guide to clinicians, public health specialists, and policymakers in the management of the COVID-19 Omicron Variant. \nInnovative technological product: The use of steaming as an adjuvant to symptomatic relief management of respiratory tract infections. \nScope of the innovative technological product: Omicron Variant produces a less severe illness than earlier variants of COVID-19. The study also reveals that vaccination alone was not effective in the prevention of contraction of the Omicron Variant and other newer variants. However, vaccination may have been advantageous in protecting the cases from progressing to severe disease. Thus, other IPCs measures must be maintained and booster doses of COVID-19 vaccinations should be encouraged. Large-scale on the effectiveness of steaming and other locally made remedies for symptomatic management of respiratory tract infections should be done.","PeriodicalId":30651,"journal":{"name":"ScienceRise","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ScienceRise","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21303/2313-8416.2022.002369","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The object of research: The study, investigated the clinical presentations of patients who tested Positive for Covid-19 (Omicron Variant), their response to treatment, and the levels of transmissibility of the infection. Investigated problem: As the globe, continent, and nation are struggling with the emergency of the new COVID-19 omicron Virant outbreak there’s not much information known about the behavior of this new threat to enable clinicians, and public health specialists, and policymakers to curb the problem. The main scientific results: The study found that headache, cough, fevers and, general body weakness was the commonest presenting complaints, 3 of the cases reported difficulties in breathing. None of the cases required admission. There was no difference in the severity of the illness and the response to treatment between the vaccinated and the non-vaccinated cases. Cases that did steaming as an adjuvant/supplementary treatment reported a shorter duration of symptomatic relief than those that did not. The area of practical use of the research results: The findings will act as a practical guide to clinicians, public health specialists, and policymakers in the management of the COVID-19 Omicron Variant. Innovative technological product: The use of steaming as an adjuvant to symptomatic relief management of respiratory tract infections. Scope of the innovative technological product: Omicron Variant produces a less severe illness than earlier variants of COVID-19. The study also reveals that vaccination alone was not effective in the prevention of contraction of the Omicron Variant and other newer variants. However, vaccination may have been advantageous in protecting the cases from progressing to severe disease. Thus, other IPCs measures must be maintained and booster doses of COVID-19 vaccinations should be encouraged. Large-scale on the effectiveness of steaming and other locally made remedies for symptomatic management of respiratory tract infections should be done.
Sars-Cov-2 B.1.1.529 (Omicron)变种爆发:乌干达伊斯兰大学卫生机构的病例系列介绍和治疗反应
研究对象:该研究调查了Covid-19 (Omicron Variant)检测呈阳性的患者的临床表现、对治疗的反应以及感染的传播水平。调查问题:随着全球、大陆和国家都在努力应对新的COVID-19 omicron Virant爆发的紧急情况,关于这种新威胁的行为知之甚少,无法使临床医生、公共卫生专家和政策制定者遏制这一问题。主要的科学结果:研究发现,头痛、咳嗽、发烧和全身无力是最常见的症状,其中3例报告呼吸困难。这些病例都不需要入院。在接种疫苗和未接种疫苗的病例之间,疾病的严重程度和对治疗的反应没有差异。蒸作为辅助/补充治疗的病例报告症状缓解的持续时间比不蒸的病例短。研究成果的实际应用领域:研究结果将作为临床医生、公共卫生专家和政策制定者管理COVID-19欧米克隆变体的实用指南。创新科技产品:使用蒸汽作为辅助治疗呼吸道感染的症状缓解管理。创新技术产品的范围:与早期的COVID-19变体相比,欧米克隆变体产生的疾病不那么严重。该研究还表明,单独接种疫苗并不能有效预防欧米克隆变异和其他新变异的收缩。然而,接种疫苗可能有利于防止病例发展为严重疾病。因此,必须维持其他ipc措施,并应鼓励加强COVID-19疫苗接种剂量。应大规模研究蒸法和其他当地治疗呼吸道感染的方法的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
17
审稿时长
3 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信